Ni. Kiskin et al., R56865 AND FLUNARIZINE AS NA-CHANNEL BLOCKERS IN ISOLATED PURKINJE NEURONS OF RAT CEREBELLUM(), Neuroscience, 54(3), 1993, pp. 575-585
Dose-related blocking effects of R56865, flunarizine and nimodipine on
voltage-activated Na+ currents recorded in the whole-cell voltage cla
mp mode were studied in acutely isolated Purkinje neurons of rat cereb
ellum. The dose-dependences of blocking action were obtained for all d
rugs at a holding potential of -110 mV and rare stimulation. At stimul
ation frequencies 5 and 15 Hz the block produced by R56865 was increas
ed showing a shift of dose-dependence to lower concentrations of antag
onist. This shift was less pronounced for flunarizine, practically abs
ent for nimodipine, and increased for all drugs with an increase in th
e amplitude of stimulating voltage pulse. With the change in holding p
otential to -80 mV the block produced by R56865 and flunarizine increa
sed showing a dose-dependence shift to lower concentrations of antagon
ists. All the drugs tested induced parallel shifts of the steady-state
voltage-dependence of inactivation of Na+ channels to more negative m
embrane potentials. R56865, and to a lesser extent flunarizine, slowed
down the recovery of Na+ channels from steady-state inactivation incr
easing the relative number of channels which showed slow recovery. In
the absence of Na+ current inactivation (treatment by intracellular pr
onase) R56865 at a concentration of 1 muM blocked modified channels pr
eferentially in the open state, while the block produced by flunarizin
e showed no dependence on voltage pulse protocol. R56865 was shown to
decrease the cell leakage while other drugs produced little or no effe
ct. It is concluded that R56865 and flunarizine block Na+ currents pre
dominantly by interacting with inactivated Na+ channels. The higher ab
ility of R56865 to block open channels and to increase slow inactivati
on underlies its higher frequency-dependence, These characteristics su
ggest the use of R56865 and flunarizine in the treatment of cerebral i
schemia.